The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
870
May 15, 1992
View Complete Issue         Table of Contents 2019 
Sertraline For Treatment Of Depression
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Sertraline For Treatment Of Depression
May 15, 1992 (Issue: 870)
Sertraline (Zoloft - Roerig), a serotonin reuptake inhibitor, was recently approved for marketing by the US Food and Drug Administration for treatment of depression. Another serotonin reuptake inhibitor, fluoxetine (Prozac), is prescribed more...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Sertraline For Treatment Of Depression
Article code: 870b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.